These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35805083)

  • 1. Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton's Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury.
    Barakat M; Hussein AM; Salama MF; Awadalla A; Barakat N; Serria M; El-Shafey M; El-Sherbiny M; El Adl MA
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
    Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
    Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
    Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
    Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanisms for the renoprotective action of adipose-derived mesenchymal stem cells with CD44-targeted hyaluronic acid against renal ischemia.
    Awadalla A; Hussein AM; Ali M; Barakat N; Hamam ET; Magar RW; Shokeir AA
    Life Sci; 2021 May; 272():119221. PubMed ID: 33609543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zinc oxide nanoparticles and ferulic acid on renal ischemia/reperfusion injury: possible underlying mechanisms.
    Awadalla A; Hussein AM; El-Far YM; Barakat N; Hamam ET; El-Sherbiny M; El-Shafey M; Shokeir AA
    Biomed Pharmacother; 2021 Aug; 140():111686. PubMed ID: 34015581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wharton's Jelly-derived mesenchymal stem cells suppress apoptosis of nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway.
    Zhao YT; Qin Y; Yang JS; Huang DG; Hu HM; Wang XD; Wu SF; Hao DJ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9807-9814. PubMed ID: 33090383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
    Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
    Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
    Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
    Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Wharton's jelly-derived mesenchymal stromal stem cells preconditioned with valproic acid promote cell migration and reduce renal inflammation in ischemia/reperfusion injury by activating the AKT/P13K and SDF1/CXCR4 pathways.
    Shokeir AA; Awadalla A; Hamam ET; Hussein AM; Mahdi MR; Abosteta AN; Shahin M; Barakat N; El-Adl M; El-Sherbiny M; Eldesoqui M; AlMadani M; Ali SK; El-Sherbini ES; Khirallah SM
    Arch Biochem Biophys; 2024 May; 755():109985. PubMed ID: 38579957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
    Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
    J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin receptor-binding nanofibrous peptide hydrogel for combined mesenchymal stem cell therapy and nitric oxide delivery in renal ischemia/reperfusion injury.
    Najafi H; Abolmaali SS; Heidari R; Valizadeh H; Tamaddon AM; Azarpira N
    Stem Cell Res Ther; 2022 Jul; 13(1):344. PubMed ID: 35883125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.
    Zou X; Zhang G; Cheng Z; Yin D; Du T; Ju G; Miao S; Liu G; Lu M; Zhu Y
    Stem Cell Res Ther; 2014 Mar; 5(2):40. PubMed ID: 24646750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.
    Lee HS; Kim KS; Lim HS; Choi M; Kim HK; Ahn HY; Shin JC; Joe YA
    J Cell Biochem; 2015 Feb; 116(2):310-9. PubMed ID: 25185536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Wharton's jelly-derived mesenchymal stem cells prevent pregnancy loss in a rat by JAK/STAT-mediated immunomodulation.
    Ding X; Wu R; Jin B; Zhu C; Zhang Y; Yang X
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2417-2426. PubMed ID: 37464974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect.
    Huang R; Zhou Q; Veeraragoo P; Yu H; Xiao Z
    Ren Fail; 2011; 33(2):207-16. PubMed ID: 21332343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid pretreatment of mesenchymal stem cells enhances the therapeutic effect on acute kidney injury.
    Zhang Y; Wang X; Ji Y; Hong H; Geng X; Zhang K; Fu Z; Cai G; Chen X; Li P; Hong Q
    Cell Commun Signal; 2024 May; 22(1):291. PubMed ID: 38802835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
    Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J
    Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
    Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
    Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macelignan protects against renal ischemia-reperfusion injury via inhibition of inflammation and apoptosis of renal epithelial cells.
    Long J; Qian K; Tan S; Liu J; Li J
    Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):55-59. PubMed ID: 32359384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.